Inscriere cercetatori

Premii Ad Astra

premii Ad Astra

Asociația Ad Astra anunță lansarea proiectului Premiilor Ad Astra 2022 (link aici), care își propune identificarea și popularizarea modelelor de succes, a rezultatelor excepționale ale cercetătorilor români din țară și din afara ei. Regulamentul de participare se poate gasi aici, iar  pagina de inscriere se poate accesa aici.

Asociatia Ad Astra a cercetatorilor romani lanseaza BAZA DE DATE A CERCETATORILOR ROMANI DIN DIASPORA. Scopul acestei baze de date este aceea de a stimula colaborarea dintre cercetatorii romani de peste hotare dar si cu cercetatorii din Romania. Cercetatorii care doresc sa fie nominalizati in aceasta baza de date sunt rugati sa trimita un email la cristian.presura@gmail.com

Elena Moldoveanu

Avatar

Victor Babes National Institute of Pathology and Biomedical Sciences, Bucharest, .

E-mail: trimite un mesaj.

Pagina web a instituţiei: http://www.ivb.ro

Nascut(a) in: 1944

Interese: Hematopatologie, Patologie hepatica umana si experimentala, Patologie cardiovasculara , Apoptoza, Stres oxidativ

flag Details:
Cardiovascular pathology
Our present research in cardiovascular pathology is regards the inflammatory state in coronary heart disease and the mechanisms of in-stent restenosis.

Publicații selectate:

* Oana Vittos, Bogdan Toana, Alexandros Vittos, Elena Moldoveanu, Lipoprotein-associated phospholipase A2 (Lp-PLA2): a review of its role and significance as a cardiovascular biomarker, Biomarkers, 2012.

* Moldoveanu Elena , Serban M, Marta DS, Serban I, Huica R, Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fraction, Biomarkers, Vol. 16, No. 7, 2011.

* Huica R, Huica S, Moldoveanu E, Flow cytometric assessment of circulating microparticles – towards a more objective analysis, Romanian Biotechnological Letters, 16(3), 2011.

* Tanaseanu C, Moldoveanu E, Tanaseanu S, Neagu M, Popescu M, Tamsulea I, Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction - a distinct clinical subset , Journal of Molecular and Cellular Cardiology, 36(5), 2004.

* Colita A, Niculescu-Mizil E, Moicean A, Ursea C, Dumitrescu A, Moldoveanu E, Ostroveanu D, Leahu S, Dobrea C, Colita D, Acute leukemia following idiopathic chronic myelofibrosis with myeloid metaplasia, British Journal of Haematology, 102 Suppl. S (1), 1998.

* Moldoveanu E, Moicean A, Colita A, Halalau F, The value of the ultrastructural pattern of myeloperoxidase and plateletperoxidase in identification of two blastic cell types during transformation of a chronic myeloproliferative disorder, HAEMATOLOGIA, 27(3), 1996.

* Tanaseanu S, Tanaseanu C, Moldoveanu E, Kosaka T, Manea G, Badea C, Diaconu C, Marta D, Cojan A, The significance of serum platelet-activating factor acetylhydrolase in systemic lupus erythematosus , Annals of the Rheumatic Diseases, 63 Suppl. 1, 2004.

* Tanaseanu C, Tanaseanu S, Moldoveanu E, Kosaka T, Tamsulea I, Badea C, Diaconu C, Endothelial protection treatment in systemic lupus erythematosus , Annals of the Rheumatic Diseases, 63 Suppl. 1, 2004.

* Tanaseanu CM, Moldoveanu E, Tanaseanu S, Marta DS, Manea G, Tamsulea I, Popescu M, Dumitrascu A, Kosaka T, Grecu V, Uscatescu V, Antiphospholipid antibodies, vascular endothelial growth factor, P-selectin and lipoprotein-associated phospholipase-A2, predictors of pulmonary arterial hypertension , Annals of The Rheumatic Diseases, 64 Suppl. 3, 2005.

* Moldoveanu E, Marta DS, Manea G, Tanaseanu RG, Tanaseanu C , Circulation adiponectin level a prognostic marker for patients with heart failure , European Journal of Heart Failure, 6 Suppl. 1, 2007.

* Tanaseanu C, Tanaseanu S, Moldoveanu E, Tamsulea I, Marta D, Ionescu R, Stoian M, Changes of interstitial cells of cajal - A cause of gastrointestinal motility disturbances in patients with systemic sclerosis , systemic sclerosis, Annals of The Rheumatic Diseases, 65 Suppl. 2, 2006.

* Tanaseanu CM, Tanaseanu S, Moldoveanu E, Dumitrascu A, Popescu M, Tamsula I, Risk factors for endothelial dysfunction in patients with systemic lupus erythematosus , Annals of The Rheumatic Diseases 66 Suppl. 2, 66 Suppl. 2, 2007.

* Opris D, Corneteanu RS, Berghea F, Bojinca V, Balanescu A, Precleteanu D, Bara C, Moldoveanu E, Ionescu R, Stoica V , Low levels of serum paraoxonase found in a cohort of Sjogren's syndrome patients, Annals of The Rheumatic Diseases, 66 Suppl. 2, 2007.

* Sfrent-Cornateanu R, Manea G, Marta DS, Mihai C Berghea F, Bara C, Moldoveanu E , Higher oxidative biomarkers associated with atherosclerosis found in a systemic sclerosis cohort , Annals of The Rheumatic Diseases, 66 Suppl. 2, 2007.

* Moldoveanu E, Marta DS, Tanaseanu G, Serban M, Serban I, Manea G, Dinca G, Kosaka T, Homocysteine thiolactonase/esterase activity of paraoxonase 1 in heart failure patients, FEBS JOURNAL, 275 Suppl. 1, 2008.

* Tanaseanu CM, Tanaseanu ST, Dumitrascu A, Tiglea I, Popescu M, Moldoveanu E, Serum lactate dehydrogenase activity - a possible parameter for vascular involvement in patients with systemic sclerosis , Clinical and Experimental Rheumatology, 28(2) Suppl.58, 2010.

* Dumitrascu A, Draghici C, Dumitrascu C, Tanaseanu ST, Moldoveanu E, Tanaseanu C, The echocardiographic parameters useful in asymptomatic patients with systemic sclerosis , Clinical and Experimental Rheumatology, 28(2), 2010.

* Moldoveanu E, Moicean A, Colita A, Halalau F, The value of the ultrastructural pattern of myeloperoxidase and plateletperoxidase in identification of two blastic cell types during transformation of a chronic myeloproliferative disorder, Haematologia, 27(3), 1996.

* Stoian I, Oros A, Moldoveanu E, Apoptosis and free radicals, BIOCHEMICAL AND MOLECULAR MEDICINE, 9(2), 1996.

* Moldoveanu E, Stoian I, Voinea L, Marta D, Popescu LM, BCL-2 - general considerations, Haematologia 31(4), 1998.

* Tanaseanu CM, Tanaseanu ST, Dumitrascu A, Tiglea I, Popescu M, Parvu M, Moldoveanu E, Macrovascular disease in patients with systemic sclerosis - predictive risk factor for severe digital vasculopathy , Clinical and Experimental Rheumatology28(2) Suppl. 58, 2010.

* Moldoveanu E,, Adiponectin levels in patients undergoing coronary stenting - Authors' Reply, , Clinical Biochemistry, 42(6), 2009.

* Moldoveanu E, Mut-Vitcu B, Tanaseanu GR, Marta DS, Manea G, Kosaka T, Vidulescu C, Tanaseanu C , Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase , Clinical Biochemistry doi:10.1016/j.clinbiochem.2008.09.109, 41(18), 2008.

* Tanaseanu C, Dumitrascu A, Tamsulea I, Popescu M, Tanaseanu S, Moldoveanu E, Importance of APLA in pathogeneis of thrombotic events associated with bacterial respiratory tract infections, Editor C D Liapis, Medimond srl,Monduzzi editore,volume ISBN 978-88-7587-423-0, 2008.

* Sfrent-Cornateanu R., Mihai C., Stoian I, Virgolici B, Lixandru D., Bara C., Moldoveanu E., Antioxidant Defense Capacity in Scleroderma Patients, Clinical Chemistry and Laboratory Medicine, 46(6), 2008.

* Tanaseanu C., Tudor S., Tamsulea I., Marta D., Manea G., Moldoveanu E., Vascular endothelial growth factor, lipoprotein- associated phospholipase A2, SP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemi, Eur J Med Res 12(3): 145-152, 2007, 12(3), 2007.

* Tanaseanu C., Moldoveanu E., Tanaseanu S., Popescu L.M., The antiphospholipid antibodies, Haematologia, 31(4), 2002.

* Serban M., Tanaseanu C., Kosaka T., Vidulescu C., Stoian I., Marta D.S., Tanaseanu S., Moldoveanu E., The significance of human platelet-activating factor acetylhydrolase in patients with non-insulin-dependent diabetes mellitus, J.Cell.Mol.Med, 6(4), 2002.

* Moldoveanu E., Moicean A, Vidulescu C., Marta D.S., Colita A., Apoptotic intensity and bcl 2 expression in patients with myelodisplastic syndrome treated with compounds which modulate proapoptotic cytokines, J.Cell.Mol.Med., 7(3), 2003.

* Sfrent-Cornateanu R., Mihai C., Balan S., Ionescu R., Moldoveanu E, The IL-6 promoter polymorphism is associated with disease activitz and distability in systemic sclerosis, J.Cell.Mol. Med, 10(4), 2006.

* Tanaseanu C., Moldoveanu E., Kosaka T., Tanaseanu S., Neagu M., Popescu L.M, The significance of human platelet-activating factor acetylhydrolase in patients with chronic stable angina, European Journal of Internal Medicine, 15(5), 2004.

* Moldoveanu E., Tanaseanu C, Tanaseanu S., Kosaka T., Manea G., Marta D.S., Popescu L.M., Plasma markers of endothelial dysfunction in type-2 diabetes patients, European Journal of Internal Medicine, 17(1), 2006.